The NHS's use of Palantir's data analytics technology has come under renewed scrutiny as concerns grow about its impact on patient care. New figures have sparked worries that some trusts may be using the system to justify reducing vital procedures, such as cancer treatments and surgeries, rather than improving them.
According to data obtained by a campaign group through Freedom of Information (FOI) requests, some NHS trusts that have implemented Palantir's technology have seen a decline in these key areas. This has led to questions about the effectiveness of the system in achieving its intended benefits.
The NHS has invested heavily in Palantir's technology as part of its drive to improve data analytics and resource allocation. However, critics argue that this investment may not be yielding the desired results, with some suggesting that alternative solutions could provide better value for money and more effective patient care.